Results 91 to 100 of about 524,357 (214)

TOXIC EPIDERMAL NECROLYSIS (LYELL’S SYNDROME)

open access: yesЖурнал инфектологии, 2018
.
E. N. Kudelka   +6 more
doaj   +1 more source

Expert consensus on oral management in autoimmune bullous diseases, erythema multiforme and SJS/TEN

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
This international Delphi study achieved expert consensus on 58 statements guiding the management of oral involvement in autoimmune bullous diseases, erythema multiforme and SJS‐TEN. The recommendations emphasize multidisciplinary care, oral hygiene and tailored topical, systemic and inpatient oral management.
Shalini Nayee   +39 more
wiley   +1 more source

A case report of toxic epidermal necrolysis associated with AZD-9291

open access: yes, 2018
Jie Wang, XianYe Cheng, Yan Lu, BingRong Zhou Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, The People’s Republic of China Abstract: Epidermal growth factor receptor-tyrosine kinase ...
Cheng XY, Lu Y, Zhou BR, Wang J
core  

Resolution of Paediatric Cow's Milk Allergy Is Associated With Low Tfh Cell Frequencies and Elevated IL‐17 and IL‐22 Levels

open access: yes
Clinical &Experimental Allergy, EarlyView.
Guillaume Lezmi   +7 more
wiley   +1 more source

Integrating Pharmacogenomic Testing Within the 4Ms Framework for Management of Behavioral Symptoms in Advanced Vascular Dementia: A Case Study

open access: yesJournal of the American Geriatrics Society, EarlyView.
Pharmacogenomic‐guided managment of behavioral symptoms within the 4Ms framework.
Gianna Franco   +3 more
wiley   +1 more source

Systemic Therapy for Paediatric Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: A Systematic Review of Current Evidence and Limitations

open access: yesJournal of Paediatrics and Child Health, EarlyView.
ABSTRACT Aim The role of systemic therapy in paediatric Stevens–Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) remains undefined. Management is primarily guided by observational data and variable practice patterns. This systematic review aims to integrate recent evidence and evaluate clinical outcomes associated with systemic therapies in ...
Samantha Ting   +3 more
wiley   +1 more source

Pathophysiology-Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis [PDF]

open access: yes, 2016
This poster examines recent research into genetic associations and emergent theories concerning the pathogenesis of Stevens-Johnson Syndrome and Toxic Epidermal ...
Klein, Douglas M.
core  

Development of Multidisciplinary Consensus‐Informed Guidance for the Management of Paediatric Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis Among Clinicians From Australasian Tertiary Referral Hospitals

open access: yesJournal of Paediatrics and Child Health, EarlyView.
ABSTRACT Background Paediatric Stevens–Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) is a rare, severe mucocutaneous reaction requiring coordinated multidisciplinary care. Existing guidelines provide evidence‐based recommendations, but implementation across tertiary paediatric hospitals requires practical consensus on local resources.
Patrick David Mahar   +32 more
wiley   +1 more source

Putative cutaneous adverse drug reactions in two dogs

open access: yesVeterinary Record Case Reports, Volume 14, Issue 4, November 2026.
Summary We describe two cases of cutaneous adverse drug reactions (CADR) in dogs. Case 1 presented with erythematous macules with sharply demarcated margins on the abdomen and inguinal area and depigmentation on the lip. Skin lesions appeared after 3 weeks of administration of anti‐epileptic drugs, including phenobarbital.
Je‐Seong Kwon   +4 more
wiley   +1 more source

Empirical Meropenem Versus Piperacillin/Tazobactam for Critically Ill Adults With Sepsis: Feasibility of a Randomised Trial

open access: yesActa Anaesthesiologica Scandinavica, Volume 70, Issue 9, October 2026.
ABSTRACT Background Meropenem and piperacillin/tazobactam are commonly used empirical antibiotics in critically ill adults with sepsis, but whether one is superior to the other is uncertain. Methods The Empirical Meropenem versus Piperacillin/Tazobactam for Adult Patients with Sepsis (EMPRESS) trial is an ongoing investigator‐initiated, randomised ...
Nick Frørup Meier   +37 more
wiley   +1 more source

Home - About - Disclaimer - Privacy